
|Videos|October 11, 2016
Specialty Pharmacy, Payer Goals in Atopic Dermatitis Management
Advertisement
Peter L. Salgo, MD; Ed Pezalla, MD, MPH; Cheryl Allen, BS Pharm, MBA; Jeffrey D. Dunn, Pharm D, MBA; and Jonathan Silverberg, MD, PhD, MPH, provide insight on specialty pharmacy and payer goals in the management of atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
5













































































































































































































